Associate Director, Analytics & Forecasting Hepatitis B Vaccines

Job Title
:
Associate Director, Analytics & Forecasting Hepatitis B Vaccines

Location
:
Morristown, NJ

The Associate Director, Analytics & Forecasting Hepatitis B Vaccines is a hybrid role with 70% dedicated to commercial analytics and insights generation and 30% focused on demand forecasting for Sanofi's Hepatitis B vaccines portfolio. The position serves as the primary analytical and forecasting expert supporting the Hepatitis B commercial organization spanning pediatric and adult vaccination programs, birth dose initiatives, catch‑up vaccination campaigns, travel medicine, and occupational health segments across endemic and non‑endemic markets.

The role transforms complex, multi‑source data into clear, actionable insights that drive business decisions across routine immunization programs, public health partnerships, and private market commercial strategy. The ideal candidate brings deep analytical rigor, a strong understanding of immunization program dynamics, and the ability to build and own end‑to‑end demand forecasts for a portfolio that spans commercial, government, and global public health channels.

This person serves as the analytical and forecasting partner to cross‑functional stakeholders including Commercial, Medical Affairs, Market Access, Finance, Supply Chain, and Global and Hub teams while owning the Hepatitis B demand forecast and providing critical data‑driven inputs that inform supply planning, brand strategy, and long‑range financial planning.

Join a global network that powers how Sanofi delivers seamlessly, purposefully, and  Manufacturing & Supply, you will help reimagine how life‑changing treatments reach people everywhere, faster.

We are an R&D‑driven, AI‑powered biopharma company committed to improving people's lives and delivering compelling growth. Our deep understanding of the immune system and innovative pipeline enables us to invent medicines and vaccines that treat and protect millions of people around the world.

(70%) ANALYTICS RESPONSIBILITIES

Commercial Analytics & Insights Generation (Primary Focus)

• Serve as the lead analytical resource for the Hepatitis B commercial organization, delivering deep‑dive analyses, ad‑hoc investigations, and proactive insights across pediatric, adult, travel medicine, and occupational health vaccination segments.
• Conduct rigorous market analysis across Hepatitis B vaccination trends, competitive landscape, immunization schedule adherence, birth dose program performance, and catch‑up vaccination uptake to generate forward‑looking commercial insights on public vs. private market dynamics specific to Hepatitis B, including government immunization programs.
• Translate complex, multi‑source data sets into clear, concise, and compelling narratives for senior leadership and cross‑functional teams.

Advanced Data Analysis & Market Intelligence

• Track and analyze vaccination coverage rates, immunization schedule completion rates (3‑dose series adherence), and catch‑up vaccination trends using CDC immunization data, IIS (Immunization Information Systems), and IQVIA data.
• Analyze endemic vs. non‑endemic market dynamics and their implications for Hepatitis B vaccine demand, pricing strategy, and commercial prioritization.
• Monitor and assess the impact of WHO pre‑qualification status, GAVI market dynamics, and global public health program changes on Hepatitis B vaccine demand and competitive positioning.

Performance Tracking & Dashboard Development

• Build and maintain scalable, automated reporting pipelines and analytical tools using Python, R, SQL, or equivalent programming languages.
• Design KPI frameworks that capture the unique performance metrics of Hepatitis B vaccination programs including birth dose coverage rates, series completion rates, healthcare provider (HCP) penetration in OB/GYN, pediatric, travel medicine, and occupational health settings.
• Ensure data quality, governance, and integrity across all analytical outputs.
• Lead ad‑hoc analytical investigations to answer critical business questions diagnosing Hepatitis B performance gaps, identifying growth opportunities in under‑vaccinated populations, and…